Group One Trading’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.09K | Buy |
+253
| New | +$1.07K | ﹤0.01% | 7132 |
|
|
2025
Q3 | – | Sell |
-7,577
| Closed | -$45K | – | 8875 |
|
|
2025
Q2 | $40.2K | Buy |
7,577
+6,585
| +664% | +$38.9K | ﹤0.01% | 5754 |
|
|
2025
Q1 | $8.8K | Buy |
+992
| New | +$11.9K | ﹤0.01% | 6344 |
|
|
2023
Q4 | – | Sell |
-4,055
| Closed | -$70.2K | – | 7891 |
|
|
2023
Q3 | $65K | Sell |
4,055
-11,541
| -74% | -$220K | ﹤0.01% | 4856 |
|
|
2023
Q2 | $362K | Buy |
15,596
+10,199
| +189% | +$223K | ﹤0.01% | 3355 |
|
|
2023
Q1 | $125K | Buy |
+5,397
| New | +$110K | ﹤0.01% | 4096 |
|
|
2022
Q3 | – | Sell |
-303
| Closed | -$6K | – | 7989 |
|
|
2022
Q2 | $6K | Hold |
303
| – | – | ﹤0.01% | 7005 |
|
|
2022
Q1 | $8K | Buy |
+303
| New | +$7.75K | ﹤0.01% | 7251 |
|
|
2021
Q4 | – | Sell |
-3,043
| Closed | -$88.2K | – | 8625 |
|
|
2021
Q3 | $98K | Buy |
3,043
+2,900
| +2,028% | +$96.3K | ﹤0.01% | 5934 |
|
|
2021
Q2 | $4K | Buy |
+143
| New | +$4.13K | ﹤0.01% | 7824 |
|
|
2020
Q4 | – | Sell |
-28,697
| Closed | -$463K | – | 6816 |
|
|
2020
Q3 | $374K | Sell |
28,697
-700
| -2% | -$8.86K | ﹤0.01% | 3106 |
|
|
2020
Q2 | $333K | Buy |
29,397
+24,047
| +449% | +$341K | ﹤0.01% | 2951 |
|
|
2020
Q1 | $77K | Sell |
5,350
-7,500
| -58% | -$158K | ﹤0.01% | 3471 |
|
|
2019
Q4 | $350K | Buy |
12,850
+1,438
| +13% | +$39.6K | ﹤0.01% | 2730 |
|
|
2019
Q3 | $327K | Buy |
11,412
+9,421
| +473% | +$275K | ﹤0.01% | 2698 |
|
|
2019
Q2 | $55K | Buy |
+1,991
| New | +$56.2K | ﹤0.01% | 3723 |
|
|
2019
Q1 | – | Sell |
-2,425
| Closed | -$70K | – | 5163 |
|
|
2018
Q4 | $70K | Sell |
2,425
-579
| -19% | -$20.8K | ﹤0.01% | 3377 |
|
|
2018
Q3 | $138K | Sell |
3,004
-3,954
| -57% | -$176K | ﹤0.01% | 3285 |
|
|
2018
Q2 | $260K | Sell |
6,958
-12,517
| -64% | -$423K | ﹤0.01% | 2845 |
|
|
2018
Q1 | $575K | Sell |
19,475
-9,898
| -34% | -$335K | 0.01% | 1948 |
|
|
2017
Q4 | $1.01M | Buy |
29,373
+28,951
| +6,860% | +$977K | 0.01% | 1692 |
|
|
2017
Q3 | $15K | Sell |
422
-31,478
| -99% | -$898K | ﹤0.01% | 4173 |
|
|
2017
Q2 | $824K | Buy |
31,900
+23,532
| +281% | +$500K | 0.01% | 1608 |
|
|
2017
Q1 | $161K | Sell |
8,368
-1,545
| -16% | -$27.4K | ﹤0.01% | 2675 |
|
|
2016
Q4 | $165K | Sell |
9,913
-2,419
| -20% | -$43.8K | ﹤0.01% | 2553 |
|
|
2016
Q3 | $254K | Sell |
12,332
-4,195
| -25% | -$106K | ﹤0.01% | 2298 |
|
|
2016
Q2 | $506K | Buy |
+16,527
| New | +$574K | 0.01% | 1727 |
|
|
2015
Q3 | – | Sell |
-27,455
| Closed | -$974K | – | 5063 |
|
|
2015
Q2 | $933K | Sell |
27,455
-26,030
| -49% | -$885K | 0.01% | 1265 |
|
|
2015
Q1 | $1.89M | Buy |
+53,485
| New | +$1.91M | 0.03% | 671 |
|
|
2014
Q4 | – | Sell |
-2,888
| Closed | -$102K | – | 5133 |
|
|
2014
Q3 | $111K | Buy |
+2,888
| New | +$108K | ﹤0.01% | 2886 |
|
Other funds holding MYGN
Group One Trading's MYGN Position: Q3 2026 in Review
Group One Trading opened a new position in Myriad Genetics (MYGN) in Q3 2026: 253 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #7132 among its holdings. This is a return to the name: Group One Trading previously reported a position in MYGN as recently as Q2 2025.
Group One Trading first reported a position in MYGN in Q3 2014 and has held it in 30 quarters since. The position peaked at $1.89M in Q1 2015. 176 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.
- Group One Trading held 253 shares of Myriad Genetics worth $1.09K as of Q3 2026.
- Myriad Genetics was a new Group One Trading position in Q3 2026.
- Myriad Genetics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7132 holding.
- Group One Trading first reported a position in Myriad Genetics in Q3 2014 and has held it in 30 quarters since.
- Group One Trading's Myriad Genetics position peaked at $1.89M in Q1 2015.
- 176 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.